Top Health Care companies in United States by Gross Profit Margin

This ranking features the top 678 Health Care companies in United States ranked by Gross Profit Margin, averaging a Gross Profit Margin of -3,266.97%, for January 15, 2025.

United States

Health Care

#	Name	Gross Profit Margin	Reported Date	Stock Price	Change	Country
1	Avalo Therapeutics, Inc. 1 AVTX	177.80%	Sept. 30, 2024	USD 6.52	-5.10%	United States
2	iBio, Inc. 2 IBIO	114.29%	Sept. 30, 2024	USD 2.73	10.08%	United States
3	Lincoln National Corporation 3 LNC	106.47%	Sept. 30, 2024	USD 31.49	2.37%	United States
4	SWK Holdings Corporation 4 SWKH	106.32%	Sept. 30, 2024	USD 16.15	-0.92%	United States
5	Arcturus Therapeutics Holdings Inc. 5 ARCT	104.50%	Sept. 30, 2024	USD 16.59	-4.16%	United States
6	Daxor Corporation 6 DXR	100.01%	June 30, 2024	USD 8.43	2.18%	United States
7	VistaGen Therapeutics, Inc. 7 VTGN	100.00%	Sept. 30, 2024	USD 2.84	-3.07%	United States
8	Apollomics, Inc. 8 APLM	100.00%	June 30, 2024	USD 10.12	-6.73%	United States
9	SeaStar Medical Holding Corporation 9 ICU	100.00%	Sept. 30, 2024	USD 1.91	-2.05%	United States
10	Perspective Therapeutics, Inc. 10 CATX	100.00%	Sept. 30, 2024	USD 3.20	-5.88%	United States
11	INmune Bio, Inc. 11 INMB	100.00%	Sept. 30, 2024	USD 5.96	-8.87%	United States
12	Xenetic Biosciences, Inc. 12 XBIO	100.00%	Sept. 30, 2024	USD 4.26	4.41%	United States
13	BeyondSpring Inc. 13 BYSI	100.00%	June 30, 2024	USD 1.65	0.61%	United States
14	VYNE Therapeutics Inc. 14 VYNE	100.00%	Sept. 30, 2024	USD 2.75	-8.94%	United States
15	Oramed Pharmaceuticals Inc. 15 ORMP	100.00%	March 31, 2024	USD 2.36	NA	United States
16	Cyclerion Therapeutics, Inc. 16 CYCN	100.00%	Sept. 30, 2024	USD 2.92	-9.60%	United States
17	Oscar Health, Inc. 17 OSCR	99.99%	Sept. 30, 2024	USD 14.93	5.36%	United States
18	MediciNova, Inc. 18 MNOV	99.98%	Sept. 30, 2023	USD 1.91	-4.02%	United States
19	Streamline Health Solutions, Inc. 19 STRM	99.84%	Oct. 31, 2024	USD 3.63	-3.20%	United States
20	Lisata Therapeutics, Inc. 20 LSTA	99.84%	Sept. 30, 2023	USD 3.64	-0.82%	United States
21	Verastem, Inc. 21 VSTM	99.83%	Sept. 30, 2024	USD 5.04	-5.62%	United States
22	Kiora Pharmaceuticals, Inc. 22 KPRX	99.74%	Sept. 30, 2024	USD 3.21	-5.87%	United States
23	Coya Therapeutics, Inc. 23 COYA	99.71%	Sept. 30, 2024	USD 5.65	-5.36%	United States
24	Ironwood Pharmaceuticals, Inc. 24 IRWD	99.60%	Sept. 30, 2024	USD 3.65	-3.18%	United States
25	Assembly Biosciences, Inc. 25 ASMB	99.48%	Sept. 30, 2024	USD 14.74	-1.01%	United States
26	Protagonist Therapeutics, Inc. 26 PTGX	99.21%	Sept. 30, 2024	USD 36.67	-1.26%	United States
27	XOMA Corporation 27 XOMA	98.94%	Sept. 30, 2024	USD 26.71	5.16%	United States
28	CytomX Therapeutics, Inc. 28 CTMX	98.88%	Sept. 30, 2024	USD 0.84	-5.23%	United States
29	Lipella Pharmaceuticals Inc. 29 LIPO	98.75%	Sept. 30, 2024	USD 3.05	0.33%	United States
30	eHealth, Inc. 30 EHTH	98.73%	Sept. 30, 2024	USD 9.30	-1.17%	United States
31	iTeos Therapeutics, Inc. 31 ITOS	98.69%	Sept. 30, 2023	USD 7.66	-1.80%	United States
32	Adial Pharmaceuticals, Inc. 32 ADIL	98.69%	Sept. 30, 2024	USD 1.02	0.99%	United States
33	Cartesian Therapeutics, Inc. 33 RNAC	98.64%	Sept. 30, 2024	USD 18.02	-1.69%	United States
34	Akero Therapeutics, Inc. 34 AKRO	98.59%	Sept. 30, 2024	USD 21.87	-3.36%	United States
35	Prime Medicine, Inc. 35 PRME	98.47%	Sept. 30, 2024	USD 2.70	-2.53%	United States
36	Corcept Therapeutics Incorporated 36 CORT	98.44%	Sept. 30, 2024	USD 51.66	1.18%	United States
37	Entrada Therapeutics, Inc. 37 TRDA	98.39%	Sept. 30, 2024	USD 12.49	-6.58%	United States
38	BridgeBio Pharma, Inc. 38 BBIO	98.31%	Sept. 30, 2024	USD 35.60	5.54%	United States
39	Aprea Therapeutics, Inc. 39 APRE	98.28%	Sept. 30, 2024	USD 3.62	5.85%	United States
40	Sagimet Biosciences Inc. 40 SGMT	98.25%	June 30, 2024	USD 4.16	-9.17%	United States
41	Arcellx, Inc. 41 ACLX	98.21%	Sept. 30, 2024	USD 64.65	-4.02%	United States
42	Enanta Pharmaceuticals, Inc. 42 ENTA	98.13%	Sept. 30, 2024	USD 4.84	-3.78%	United States
43	Neurocrine Biosciences, Inc. 43 NBIX	98.00%	Sept. 30, 2024	USD 139.51	-2.46%	United States
44	BioCryst Pharmaceuticals, Inc. 44 BCRX	97.91%	Sept. 30, 2024	USD 7.23	-8.83%	United States
45	Zentalis Pharmaceuticals, Inc. 45 ZNTL	97.68%	Sept. 30, 2024	USD 2.65	3.52%	United States
46	AVITA Medical, Inc. 46 RCEL	97.62%	Sept. 30, 2023	USD 8.89	0.79%	United States
47	Daré Bioscience, Inc. 47 DARE	97.57%	Sept. 30, 2024	USD 3.34	0.30%	United States
48	Day One Biopharmaceuticals, Inc. 48 DAWN	97.37%	Sept. 30, 2024	USD 11.16	-3.46%	United States
49	Ionis Pharmaceuticals, Inc. 49 IONS	97.30%	Sept. 30, 2024	USD 32.69	-6.44%	United States
50	Dominari Holdings Inc. 50 DOMH	97.16%	Sept. 30, 2024	USD 1.03	-0.96%	United States

1 2 3 4 … 14

Frequently Asked Questions

Which Health Care company in United States has the highest Gross Profit Margin ?

The Health Care company in United States with the highest Gross Profit Margin is Avalo Therapeutics, Inc. (NasdaqCM: AVTX) at 177.80%.
Which Health Care company in United States has the lowest Gross Profit Margin ?

The Health Care company in United States with the lowest Gross Profit Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,970,400.00%.

What are the top 10 Health Care companies in United States by Gross Profit Margin ?

The top 10 Health Care companies in United States by Gross Profit Margin are Avalo Therapeutics, Inc., iBio, Inc., Lincoln National Corporation, SWK Holdings Corporation, Arcturus Therapeutics Holdings Inc., Daxor Corporation, VistaGen Therapeutics, Inc., Apollomics, Inc., SeaStar Medical Holding Corporation and Perspective Therapeutics, Inc..
What are the bottom 10 Health Care companies in United States by Gross Profit Margin ?

The bottom 10 Health Care companies in United States by Gross Profit Margin are Inhibikase Therapeutics, Inc., Allogene Therapeutics, Inc., Checkpoint Therapeutics, Inc., Revolution Medicines, Inc., Chimerix, Inc., PureTech Health plc, Sharps Technology, Inc., Alaunos Therapeutics, Inc., Altimmune, Inc. and Kyverna Therapeutics, Inc..